Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 5.

Schmalfeld, B; Brambs, A; Burges, A; El-Balat, A; Emons, G; Fink, Daniel; Fotopoulou, M; Gropp-Meier, M; Hanker, L; Harter, P; Hasenburg, A; Hauptmann, S; Hilpert, F; Kimmig, R; Kommoss, S; Kurzeder, C; Mahner, S; Marmé, F; Mayr, D; Meier, W; Mainhold-Heerlein, I; Mustea, A; Ortmann, O; Oskay-Özcelik, G; Pfisterer, J; Pölcher, M; Runnebaum, I; Schröder, W; Tanner, B; Wagner, U; Wimberger, P; Sehouli, J (2018). Wie ist die Evidenz für die Lyphonodektomie beim frühen Ovarialkarzinom? Der Frauenarzt, 59(10):751-753.

Fink, D; Schmalenfeldt, B; du Bois, A; Burges, A; Emons, G; Gropp, M; Harter, P; Hasenburg, A; Hauptmann, S; Jäger, W; Kimmig, R; Kommoss, F; Kreienberg, R; Kuhn, W; Meier, W; Münstedt, K; Ortmann, O; Pfisterer, J; Richter, B; Runnebaum, I; Schröder, W; Sehouli, J; Tanner, B; Wagner, U (2008). Aktuelle und zukünftige Entwicklungen in der Diagnostik und Therapie des Ovarialkarzinoms. Geburtshilfe und Frauenheilkunde, 68(4):382-388.

Hengstler, J G; Lange, J; Kett, A; Dornhöfer, N; Meinert, R; Arand, M; Knapstein, P G; Becker, R; Oesch, F; Tanner, B (1999). Contribution of c-erbB-2 and topoisomerase IIalpha to chemoresistance in ovarian cancer. Cancer Research, 59(13):3206-3214.

Hengstler, J G; Kett, A; Arand, M; Oesch-Bartlomowicz, B; Oesch, F; Pilch, H; Tanner, B (1998). Glutathione S-transferase T1 and M1 gene defects in ovarian carcinoma. Cancer Letters, 130(1-2):43-48.

Tanner, B; Hengstler, J G; Luch, A; Meinert, R; Kreutz, E; Arand, M; Wilkens, C; Hofmann, M; Oesch, F; Knapstein, P G; Becker, R (1998). C-myc mRNA expression in epithelial ovarian carcinomas in relation to estrogen receptor status, metastatic spread, survival time, FIGO stage, and histologic grade and type. International Journal of Gynecological Pathology, 17(1):66-74.

This list was generated on Mon Apr 22 02:55:36 2019 CEST.